BRAF and colorectal cancer: Although both subsets derive from a serrated polyp due to the presence of the BRAF mutation and are clinically associated with a detrimental patient outcome, BRAF mutant/MSS colorectal cancers diverge from BRAF/MSI cancers with the development of clinicopathologically and genetically distinct aberrations [27].